Literature DB >> 26116341

Verteporfin Photodynamic Therapy for the Treatment of Retinal Vasoproliferative Tumors.

Rumana N Hussain1, Fidan Jmor2, Bertil Damato3, Heinrich Heimann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26116341     DOI： 10.1016/j.ophtha.2015.05.026

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  5 in total

1.  Silibinin relieves UVB-induced apoptosis of human skin cells by inhibiting the YAP-p73 pathway.

Authors:  Wei-Wei Liu; Fang Wang; Can Li; Xiao-Yu Song; Wuxiyar Otkur; Yu-Ying Zhu; Toshihiko Hayashi; Kazunori Mizuno; Shunji Hattori; Hitomi Fujisaki; Takashi Ikejima
Journal:  Acta Pharmacol Sin       Date:  2021-12-15       Impact factor: 7.169

2.  Macular sequelae in vasoproliferative tumors: results of surgical approach.

Authors:  Asterios Diafas; Victoria Toumanidou; Ioannis Kassos; Maria Samouilidou; Anna Dastiridou; Nikolaos Ziakas; Sofia Androudi
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

3.  Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft.

Authors:  Jonathan W Kim; Bradley Jacobsen; Emily Zolfaghari; Angela Ferrario; Patricia Chevez-Barrios; Jesse L Berry; Diana K Lee; Grecia Rico; Ingy Madi; Narsing Rao; Kevin Stachelek; Lei-Chi Wang; Charles Gomer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-02       Impact factor: 3.117

4.  Management of Vasoproliferative Tumors of the Retina with Macular Complications by Pars Plana Vitrectomy Combined with Episcleral Cryotherapy.

Authors:  Wenhua Zhang; Zeyuan Qiang; Hao Song; Xiaoli Li; Handong Dan; Keke Ge; Pan Li; Zixu Huang; Dongdong Wang; Feng Chen; Bin Zheng; Zongming Song
Journal:  J Ophthalmol       Date:  2021-04-13       Impact factor: 1.909

Review 5.  The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor.

Authors:  Changran Wei; Xiangqi Li
Journal:  Front Pharmacol       Date:  2020-10-15       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.